Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

By his estimate, that means AI has been around at Sanofi for about a third of the "discovery" process for some drugs. That ...

showcase AI’s potential to accelerate drug development Researchers have applied AI and machine learning to every stage of the ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.